Federation des caisses Desjardins du Quebec
Position in OTLK — Outlook Therapeutics, Inc.
CIK 2022297
LEVIS, A8
Position in OTLK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$270
-$1,802 QoQ
Shares Held
1,312
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 54 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in OTLK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Federation des caisses Desjardins du Quebec holds $43,872,219 across 136 Biotechnology names. OTLK ranks #121 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,252 | $7,148,462 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,955 | $7,124,544 | |
| 3 | ARGX |
Argenx SE
|
6,919 | $5,052,599 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,731 | $3,881,433 | |
| 5 | INCY |
Incyte Corp
|
31,446 | $2,959,696 | |
| 6 | TECH |
BIO-TECHNE Corp
|
38,673 | $2,021,050 | |
| 7 | MRNA |
Moderna, Inc.
|
37,887 | $1,924,658 | |
| 8 | INSM |
INSMED Inc
|
11,517 | $1,883,258 |
All Filings in OTLK
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $270 | 1,312 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,072 | 1,312 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,390 | 1,312 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,099 | 1,312 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,600 | 1,312 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||